Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Sanofi, Regeneron and COPD
Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD
Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary disease received approval from the Food and Drug Administration.
Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent
Regeneron stock XX on XX after the company won FDA approval for Dupixent in chronic obstructive pulmonary disease, or COPD.
Regeneron, Sanofi's Dupixent Get FDA Approval For Chronic Obstructive Pulmonary Disease Treatment
Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNY), Friday announced that the U.S. Food and Drug Administration has approved
12h
Regeneron: Long-Term Defensive Investment
Regeneron's R&D expenses are projected to reach $5 billion, but the business remains highly profitable. Read why I rate REGN ...
2d
Sanofi blockbuster drug wins clearance in US for lung disease
Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after ...
2d
Sanofi/Regeneron’s Dupixent set to dominate COPD biologics market following FDA approval
Dupixent has gained positive opinions from KOLs due to the positive data presented from the asset’s two Phase III clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Helene death toll rises
'Days of Our Lives' star dies
Vance’s Pennsylvania rally
Hospitalized for burns
'SNL' launches 50th season
Malibu coast earthquake
Trump to visit Fayetteville
Chief adviser subpoenaed
Rescue mission launched
Earth's orbit new asteroid
NC dam failure ‘imminent’
Faces fine to end Brazil ban
Steward CEO to step down
Ukrainian drones shot down
ISR strikes Lebanon again
On Hezbollah leader's killing
Szarewicz case update
Deposition in AI suit
NY ballot appeal rejected
KY sues Express Scripts
Haney sues Garcia
Congestion fee bid denied
High-end brothel plea
Dow closes at record high
Houthis attack US warships
121st loss of the season
Van Gogh paintings attacked
Diocese reaches settlement
Congressional Gold Medal
UNC digital IDs blocked
Human rabies death in MN
ICE: Convicts roaming free
Feedback